Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: A retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 117, Issue 2, 2014, Pages 204-213

  Schiodt, Morten ^a   Reibel, Jesper ^a   Oturai, Peter ^b   Kofod, Thomas ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; DENMARK; FEMALE; HUMAN; JAW OSTEONECROSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84892865134     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2013.10.010     Document Type: Article

References (23)

1. G.J. Morgan, F.E. Davies, and W.E. Gregory et al. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial Lancet 376 2010 1989 1999
2. K. Fizazi, M. Carducci, and M. Smith et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study Lancet 377 2011 813 822
3. C.H. Van Poznak, S. Temin, and G.C. Yee et al. American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer J Clin Oncol 29 2011 1221 1227
4. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
5. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534
6. T. Mavrokokki, A. Cheng, B. Stein, and A. Goss Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 2007 415 423
7. J. Bagan, C. Scully, V. Sabater, and Y. Jimenez Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): a concise update Oral Oncol 45 2009 551 554
8. C.A. Migliorati, S.B. Woo, and I. Hewson et al. A systematic review of bisphosphonate osteonecrosis (BON) in cancer Support Care Cancer 18 2010 1099 1106
9. S. Otto, M.K. Abu-Id, and S. Fedele et al. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence - a multi-centre study J Craniomaxillofac Surg 39 2011 272 277
10. S.L. Ruggiero, J. Fantasia, and E. Carlson Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 2006 433 441
11. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws Advisory Task Force on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 65 2007 369 376
12. C.A. Migliorati, J. Casiglia, J. Epstein, P.L. Jacobsen, M.A. Siegel, and S.B. Woo Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper J Am Dent Assoc 136 2005 1658 1668
13. American Dental Association Council on Scientific Affairs Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations J Am Dent Assoc 137 2006 1144 1150
14. S.L. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, R.E. Marx, and B. Mehrotra Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update Aust Endod J 35 2009 119 130
15. L. Junquera, and L. Gallego Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? J Oral Maxillofac Surg 66 2008 1516 1517
16. J.V. Bagan, Y. Jimenez, and J.M. Diaz et al. Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification Oral Oncol 45 2009 645 646
17. H. Mawardi, N. Treister, and P. Richardson et al. Sinus tracts - an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg 67 2009 593 601
18. N. Yarom, S. Fedele, T.S. Lazarovici, and S. Elad Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaws? J Oral Maxillofac Surg 68 2010 705 709
19. T.S. Lazarovici, R. Yahalom, and S. Taicher et al. Bisphosphonate related osteonecrosis of the jaws: a single-center study of 101 patients J Oral Maxillofac Surg 67 2009 850 855
20. S. Fedele, S.R. Porter, and F. D'Aiuto et al. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series Am J Med 123 2010 1060 1064
21. J.V. Bagan, E. Hens-Aumente, M. Leopoldo-Rodado, M. Poveda-Roda, and L. Bagan Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases Oral Oncol 48 2012 753 757
22. S. Patel, S. Choyee, and J. Uyanne et al. Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines Oral Dis 18 2012 625 632
23. M. Hutchinson, F. O'Ryan, and V. Chavez et al. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure J Oral Maxillofac Surg 68 2010 2232 2240